Cytolytic activity of peptides derived from the Cry11Bb insecticidal toxin of B. thuringiensis subsp. medellin

Santiago Rendon-Marin1, Carolina Quintero-Gil1, Victor V Lemeshko2

  • 1Escuela de Biociencias, Facultad de Ciencias, Universidad Nacional de Colombia Sede Medellín, Carrera 65 No. 59A - 110, Medellín, 050034, Colombia.

Insights

Eight peptides from Bacillus thuringiensis Cry11Bb protoxin showed cell-killing activity against human cancer cells. The most effective peptides induced apoptosis, a programmed cell death pathway, and permeabilized cell membranes, suggesting potential for cancer therapy development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Bacillus thuringiensis (Bt) Cry proteins, specifically parasporins, inhibit cancer cell proliferation.
  • Protease activation is key for parasporin activity against cancer cells.
  • Cry11Bb protoxin from B. thuringiensis subsp. medellin is a source of potential anti-cancer peptides.

Purpose of the Study:

  • To evaluate eight peptides derived from Cry11Bb protoxin for membrane permeabilization and cytolytic activities.
  • To investigate the mechanism of action, including apoptosis induction and membrane potential dependence.
  • To identify promising peptides for potential cancer therapeutic applications.

Main Methods:

  • Peptide selection from Cry11Bb protoxin.
  • Assay of membrane permeabilization using red blood cells.
  • Cytotoxicity assessment on A549, MCF-7, and Caco-2 cancer cell lines.
  • Hemolysis assays.
  • AnnexinV-FLUOS staining for apoptosis detection.
  • Real-time PCR for p53 transcription analysis.

Main Results:

  • Selected peptides demonstrated membrane permeabilization in a membrane potential-dependent manner.
  • Half maximal inhibitory concentrations (IC50) in cancer cells ranged from 0.78–7.63 μM.
  • Hemolysis percentages at 25 μM peptide concentration varied from 4.6–32.4%.
  • Peptides BTM-P1 and BTM-P4 showed the lowest IC50 values against MCF-7 cells.
  • BTM-P1 induced apoptosis in MCF-7 cells, evidenced by AnnexinV staining and increased p53 transcription.

Conclusions:

  • Polycationic peptides from Cry11Bb protoxin exhibit cytolytic activity against cancer cells.
  • The mechanism involves potential-dependent membrane permeabilization and induction of apoptosis.
  • Peptides BTM-P1 and BTM-P4 are promising candidates for further investigation in cancer therapy.
  • Further studies are warranted to explore efficacy against other cancer types and solid tumors.